The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|November 21, 2018
First Recreational Cannabis Sales Begin on East Coast
Author(s)Megan L'Heureux
Advertisement
November 20, 2018 marked the first East Coast sales for recreational cannabis in the United States. Two retail locations in Massachusetts opened their doors to customers-Cultivate in Leicester and New England Treatment Access (NETA) in Northampton.
According to local reports (1), customers waited in long lines but were excited to be part of history. The stores were stocked with various products ranging from different strains of bud, pre-rolled joints, and edibles such as brownies and chocolate bars. Both stores were well prepared with products and no shortages were reported.
Massachusetts predicts its cannabis market has the potential to be a $1.5 billion/year industry. However, it has been more than two years since Massachusetts voters approved adult recreational use. Critics blame the slow roll out on a number of causes such as the slow pace of the state to issue regulations and licenses as well as opposition from specific towns and cities that don’t want cannabis businesses in their area. The Cannabis Control Commission issued two additional licenses on November 20 to stores in Salem and Easthampton, both of which should open in the coming weeks.
References:
Newsletter
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.
SubscribeAdvertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement